(Q43363077)

20 November 2017

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial (English)

1 reference

20 November 2017

0 references

1 reference

1 reference

Patrizia Brigidi

6

0 references

Fernando Rizzello

Fernando Rizzello

2

0 references

Massimo Campieri

Massimo Campieri

10

0 references

Paolo Gionchetti

Paolo Gionchetti

1

0 references

Gilberto Poggioli

8

Gilberto Poggioli

1 reference

20 November 2017

7

Beatrice Vitali

1 reference

20 November 2017

3

Ulf Helwig

1 reference

20 November 2017

5

Karen Manon Lammers

1 reference

20 November 2017

Alessandro Venturi

4

1 reference

PubMed ID

12730861

20 November 2017

Mario Miglioli

9

1 reference

PubMed ID

12730861

20 November 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

20 November 2017

1 reference

20 November 2017

124

1 reference

20 November 2017

1202-1209

1 reference

20 November 2017

5

1 reference

Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment

20 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Long-term functional outcome and quality of life after stapled restorative proctocolectomy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Restorative proctocolectomy with ileal reservoir: pathological and histochemical study of mucosal biopsy specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Probiotics in inflamatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Probiotic bacteria enhance murine and human intestinal epithelial barrier function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

A basic program for constructing a dispensing list for a randomised clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Evaluation of media for selective enumeration of Streptococcus thermophilus, Lactobacillus delbrueckii ssp. bulgaricus, Lactobacillus acidophilus, and bifidobacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Development of oligonucleotide primers from the 16S-23S rRNA intergenic sequences for identifying different dairy and probiotic lactic acid bacteria by PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Specific detection and analysis of a probiotic Bifidobacterium strain in infant feces

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Specific detection of bifidobacterium strains in a pharmaceutical probiotic product and in human feces by polymerase chain reaction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Pouchitis: result of microbial imbalance?

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900171-9

10.1016/S0016-5085(03)00171-9

7 January 2021

Identifiers

DOI

1 reference

20 November 2017

1 reference

PubMed ID

12730861